Research advances in drug-induced autoimmune-like hepatitis
- VernacularTitle:药物诱导的自身免疫样肝炎的研究进展
- Author:
Qinrong LI
1
;
Ying YAO
;
Zhiyuan XU
Author Information
- Keywords: Chemical and Drug Induced Liver Injury; Hepatitis,Autoimmune; Diagnosis; Therapeutics
- From: Journal of Clinical Hepatology 2024;40(6):1255-1258
- CountryChina
- Language:Chinese
- Abstract: Drug-induced autoimmune-like hepatitis(DI-ALH)is a special clinical phenotype of drug-induced liver injury and has similar clinical features and laboratory test results to autoimmune hepatitis,and it is often difficult to distinguish them through liver biopsy.Therefore,correct differential diagnosis DI-ALH and autoimmune hepatitis is a crucial and difficult point in clinical practice.This article analyzes the research advances in the pathogenesis,clinical features,diagnosis and treatment,and prognosis of DI-ALH,in order to provide ideas for the diagnosis and treatment of such diseases among clinicians.
